Multiparametric infectious diseases Point-of-Care

HIV, Hepatitis B & C

Because everybody deserves high quality care

Transforming the linkage to care

MagIA diagnostics Point-of-care screening will transform the way patients are linked to care

Multiplexed
Fast
Small sample
Portable

Syndromic testing

MagIA diagnostics offers a new approach allowing the screening of HIV and its coinfections hepatitis B and C in a single test using capillary blood. With its ability to test 2 cartridges at the same time, our system to test up to 8 markers at the point of care. Our portable and syndromic approach provides benefits to healthcare professionals allowing more people to be tested in less time, resulting in a better linkage to care of the patients.

One system – endless testing

MagIA diagnostics will offer a large panel of syndromic testing panels – all based on the same analyzer

Analyzer

Disrupting today’s blood-testing standards, the MagIA diagnostic Analyzer brings laboratory quality testing to the Point-of-Care. Compared to lateral flow assay, our device-based approach allows for a simplified and enhanced traceability of patient data. This portable system is designed for effortless and straightforward operation, making it suitable for both medical and non-medical professionals

Cartridges

The cornerstone of our system’s flexibility and simplicity lies in our single-use cartridges. Each cartridge is designed to cover a distinct panel of related markers while maintaining compatibility with our analyzer. Just load your sample and analyze up to two cartridges simultaneously – it’s that easy!

Latest news

The latest updates from MagIA diagnostics

Le projet MAGFA obtient un financement européen

[hashtag#LBPmember] 📢 Le projet MAGFA reçoit un financement européen de 5 millions d’Euros. Ce projet, accompagné par Lyonbiopôle Auvergne-Rhône-Alpes, est porté par la société MagIA diagnostics en collaboration avec l’Institut Pasteur ainsi que 5 acteurs d’Afrique...

read more

MAGICIEN clinical study!

EN| Here we go! We are entering Phase 3 of our MAGICIEN clinical study! Thursday, Paul and Damien went to the European Hospital of Marseille to launch this third phase where around 50 patients will be tested. Our goal: to validate the sensitivity and specificity of...

read more

Get in touch

MagIA diagnostics SAS

15 rue Maréchal Leclerc

38130 Echirolles

France